Keywords: medimmune, rsv, antibody, phase, iii, begun, trial

MedImmune RSV Antibody In Phase III

Article | 02 December 1996

Print This

MedImmune has begun a Phase III trial to evaluate the safety and efficacy of MEDI-493, the firm's humanized monoclonal antibody ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in